During the past decade, The Third Affiliated Hospital of Qiqihar Medical University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Third Affiliated Hospital of Qiqihar Medical University" #1 sponsor was "Angde Biotech Pharmaceutical Co., Ltd." with 1 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored, "Harbin Medical University" with 1 trials sponsored, "Shanghai Henlius Biotech" with 1 trials sponsored and "Shenyang Northern Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Third Affiliated Hospital of Qiqihar Medical University" #1 collaborator was "Beijing Tiantan Hospital" with 1 trials as a collaborator, "Chinese Society of Cardiology" with 1 trials as a collaborator, "Guangdong Provincial People's Hospital" with 1 trials as a collaborator and "Lepu Medical Technology (Beijing) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Third Affiliated Hospital of Qiqihar Medical University" are "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Advanced Cervical Cancer" (1 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "The Third Affiliated Hospital of Qiqihar Medical University" in a lesser frequency.

Most popular intervention types in "The Third Affiliated Hospital of Qiqihar Medical University" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aspirin monotherapy" (1 trials), "Clopidogrel and Aspirin dual-antiplatelet therapy" (1 trials), "HLX10" (1 trials) and "Injection of recombinant human tissue plasminogen kinase derivatives" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Third Affiliated Hospital of Qiqihar Medical University" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Third Affiliated Hospital of Qiqihar Medical University". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Third Affiliated Hospital of Qiqihar Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Third Affiliated Hospital of Qiqihar Medical University, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".